KKR buys stake in Malaysia’s Avisena in healthcare push
The investment will drive the healthcare company’s next phase of growth; financial details have not been given
KKR, the investment firm, has acquired a minority stake in Malaysia's Avisena Healthcare, expanding its involvement in the region's healthcare sector. The financials of the deal have not been disclosed, but KKR intends to use this purchase to propel Avisena's growth by expanding its multi-specialty offerings and constructing new greenfield hospitals in the Klang Valley.
The firm did not reveal the specific stake or the investment amount to Reuters. Avisena has not yet provided further details on the acquisition. In August, Reuters had reported that KKR was the leading candidate to buy 20 to 25 percent of Avisena, a deal potentially worth RM300 million to RM400 million. KKR's healthcare portfolio in the Asia-Pacific region includes Medical Saigon Group in Vietnam, Metro Pacific Hospital in the Philippines, and Japan's Topcon, among others.
As incomes rise, populations age, and demand for private medical treatment increases in Southeast Asia, investor interest in healthcare assets in the region has grown.
Written by urgent.news from The Business Times - Companies & Markets's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
